Lovastatin blocks basic fibroblast growth factor-induced mitogen-activated protein kinase signaling in coronary smooth muscle cells via phosphatase inhibition

European Journal of Cell Biology

Volumn 80, Issue 3, 2001, Pages 207-212

  Skaletz Rorowski, Adriane ^a   Müller, Joachim G ^a   Kroke, Annette ^a   Waltenberger, Johannes ^b   Pulawski, Ewa ^a   Pinkernell, Kai ^a   Breithardt, Günter ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

3 hydroxy 3 methyl glutaryl coenzyme A reductase; Basic fibroblast growth factor; Coronary smooth muscle cells; Mitogen activated protein kinase; Protein kinase C; Protein phosphatase PP 1 PP 2A

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; BASIC FIBROBLAST GROWTH FACTOR; BINDING PROTEIN; CALYCULIN A; DNA; ENZYME ANTIBODY; ENZYME INHIBITOR; FARNESYL DIPHOSPHATE; GROWTH FACTOR RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPROTEIN; MEMBRANE RECEPTOR; MEVALONIC ACID; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEOHEPARAN SULFATE; RAS PROTEIN; THYMIDINE DERIVATIVE; TRANSCRIPTION FACTOR; TRITIUM; TYROSINE KINASE RECEPTOR; UNINDEXED DRUG;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORONARY ARTERY; DEPHOSPHORYLATION; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALIA; TRITIUM;

EID: 0035081609     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-9335-00155     Document Type: Article

References (28)

1. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosin phosphatase, but not CL100, in various cell lines
2. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor
3. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells
4. Multiple intracellular MAP kinase signaling cascades
5. Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase C α
6. Mitogen-activated protein kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and anitisense oligonucleotides
7. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction
8. Regulation of the mevalonate pathway
9. Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells
10. KIP1 accumulation during the cell cycle
11. Regulation of syndecan-4 phosphorylation in vivo
12. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
13. Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis
14. Stimulation of protein kinase C activity by compactin in vascular smooth muscle cells
15. Kip1
16. Growth factors stimulate tyrosine dephosphorylation of p75 and its dissociation from the SH2 domain of Grb2
17. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries: An en face study
18. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor
19. Linking protein kinase C to the cell cycle: Ectopic expression of PKCh in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis
20. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
21. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells
22. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis
23. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway
24. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis
25. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteo-heparan sulfate in cultured coronary smooth muscle cells
26. Protein kinase C mediates basic fibroblast growth factor-induced proliferation through mitogen activated protein kinase in coronary smooth muscle cells
27. The mitogen-activated protein kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic
28. Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts